Sabine Maamari

Dr Sabine Maamari is the Chief Operating Officer of Avocet Bio, a German biotechnology company developing programmable RNA medicines. She leads the company’s operational strategy, partnerships, non-clinical development, and funding activities. Her work focuses on translating innovative RNA technologies into therapeutic programmes, particularly in cardiovascular disease and fibrosis. She holds a PhD in Molecular Medicine, with a focus on cardiovascular epigenetics.